Pricing Log in Create free account

Innate Pharma S.A. Sponsored ADR (IPHA) vs PepGen, Inc. (PEPG)

Innate Pharma S.A. Sponsored ADR and PepGen, Inc. are both Biotechnology companies. Innate Pharma S.A. Sponsored ADR and PepGen, Inc. are of similar size ($171.1M and $160.9M). PepGen, Inc. has the higher net margin (0.00% vs −99.7%) and the lower return on invested capital (−2,076.3% vs 0.00%). Across the 10 metrics below, Innate Pharma S.A. Sponsored ADR leads on 6 and PepGen, Inc. on 4.

Valuation

Metric IPHA PEPG Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B n/m 1.43 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 0.12 n/m 9.02
Earnings yield (81.01%) (53.04%) (32.88%)
Free cash flow yield 0.00% (40.66%) (23.13%)

Profitability

Metric IPHA PEPG Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin (99.70%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (75.45%) (51.96%)
Return on assets 0.00% (59.06%) (46.06%)
Return on invested capital 0.00% (2,076.25%) 0.00%

Growth

Metric IPHA PEPG Biotechnology median
Revenue growth (TTM) (4.17%) — 6.76%
EPS growth (last fiscal year) 6.06% 25.61% 29.88%
Revenue growth, 5-year CAGR (33.86%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IPHA PEPG Biotechnology median
Debt to equity (0.50) 0.00 0.00
Current ratio 0.60 13.36 4.97
Net debt to EBITDA 0.22 1.64 1.01

Dividend

Metric IPHA PEPG Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IPHA PEPG Biotechnology median
Market cap 160.85m 171.07m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack